Back to Agenda
International Regulatory Cooperation with the African Medicines Agency
Session Chair(s)
Representative Invited
FDA African Medicines Agency Liaison Office, United States
A 60-minute session with AMA, FDA, and partners will review successes in collaboration, explore future opportunities to enhance oversight and access, and conclude with interactive Q&A on advancing harmonized regulatory systems in Africa.
Learning Objective : Discuss the FDA priorities in regulatory alignment, supply chain resilience, and collaboration in Africa; Recognize how regulators work across regions to improve access, using approaches such as reliance, convergence, and joint inspections to reduce duplication, strengthen resilience, and advance public health.
Speaker(s)
International Regulatory Cooperation with the African Medicines Agency
Delese Mimi Darko, MBA, RAC
African Medicines Agency (AMA) , Rwanda
Director General
International Regulatory Cooperation with the African Medicines Agency
Alioune Ibnou Abou Talib Diouf
Agence Sénégalaise de Réglementation Pharmaceutique (ARP), Senegal
Director General
International Regulatory Cooperation with the African Medicines Agency
Heran Gerba, PHD
Ethiopian Food and Drug Authority (EFDA), Ethiopia
Director General
International Regulatory Cooperation with the African Medicines Agency
Ahmed Mohamed
Pharmacy and Poisons Board, Kenya
Chief Executive Officer
Have an account?